ArticleBMC pediatrics2026
Clinical significance and management of antenatally detected hydronephrosis due to ureteropelvic junction obstruction: a retrospective single-center study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntenatal hydronephrosis (ANH) is a common prenatal finding with a heterogeneous postnatal course. This study aims to describe an institutional experience and protocol adherence regarding the clinical course, intervention timing, and surgical outcomes of severe ANH secondary to ureteropelvic junction obstruction (UPJO) and its rare coexistence with ureterovesical junction obstruction (UVJO).
methodsWe retrospectively reviewed the records of infants referred to our tertiary center with severe prenatal urinary tract dilation (UTD A2-3 / high risk). Out of 400 initially screened patients, 80 infants who completed a standardized 1-year postnatal follow-up protocol were included, representing a highly selected completer cohort. Postnatal evaluation included serial ultrasounds (USG) and mercatoacetyltriglycine 3 (MAG-3) renography. Surgical intervention (dismembered pyeloplasty) was indicated based on standardized empirical consensus criteria: anterior-posterior renal pelvic diameter (APRPD) ≥ 19 mm, parenchymal thickness ≤ 5 mm, or split differential renal function (DRF) ≤ 40% with obstructive clearance patterns. Postoperative complications were graded using the Clavien-Dindo classification.
resultsThe final analysis included 80 infants. Isolated UPJO was diagnosed in 12 patients (15.0%), transient/physiological hydronephrosis in 35 (43.75%), vesicoureteral reflux (VUR) in 29 (36.25%), and coexisting UPJO and UVJO in 4 patients (5.0%). Pyeloplasty was performed in all 12 isolated UPJO patients and 4 coexisting UPJO+UVJO patients (total n = 16 surgical cases) at a median age of 3 months. Postnatal USG at 12 months demonstrated a significant reduction in pelvic dilatation and marked parenchymal thickening. No deterioration in renal function was observed during follow-up, and no postoperative complications were recorded in this cohort.
conclusionAdherence to a strict, conservative management protocol with standardized surgical thresholds was associated with favorable outcomes in high-risk ANH patients. Given the single-center descriptive nature and substantial loss-to-follow-up within this completer cohort, these findings represent descriptive institutional experiences rather than statistically validated threshold models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.